Clinical trials: active, in Rwanda
HIV (Human Immunodeficiency Virus), HPV
Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda
Cervical cancer disproportionately affects women in low- and middle-income countries (LMICs), particularly women living with HIV (WLWH) who have a 6-fold increased risk of cervical cancer compared to women in the general…
- Conditions
- HIV (Human Immunodeficiency Virus), HPV, Cervical Precancer
- Trial name
- NCT07390916
- Testing
- Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes
- Where
- Rwanda
- Volunteers
- 300 people
- Sponsor
- Fred Hutchinson Cancer Center
Uncomplicated Plasmodium Falciparum Malaria
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)
This was Cohort C2 of the Platform study (NCT05750628) to evaluate the efficacy and safety of Cipargamin + KLU156 in participants with uncomplicated Plasmodium falciparum malaria.
- Trial name
- PLATINUM (NCT07811908)
- Testing
- KAE609, SoC (Coartem), KLU156
- Where
- 13 sites in Burkina Faso, Côte d’Ivoire and 5 more
- Volunteers
- 120 people
- Sponsor
- Novartis Pharmaceuticals
Fetal Weight, Pregnancy
Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation
Purpose: The primary objective of this study is to assess the diagnostic accuracy of an AI-enabled ultrasound tool for estimating fetal weight Participants: 1,000 pregnant individuals Procedures (methods): This prospective…
- Conditions
- Fetal Weight, Pregnancy, Machine Learning, Pregnancy - Prenatal Testing
- Trial name
- krittenhouse (NCT07661433)
- Testing
- AI ultrasound diagnostic tool for fetal weight estimation
- Where
- 6 sites in United States, Canada and 2 more
- Volunteers
- 1,000 people
- Sponsor
- University of North Carolina, Chapel Hill
Heart Failure
Heart Failure Self Care Education in Rwanda
In Rwanda, patients with heart failure may have low health education about their condition. Heart failure care requires active patient involvement.
- Trial name
- NCT07722468
- Testing
- HF Education
- Where
- Rwanda
- Volunteers
- 400 people
- Sponsor
- Boston Medical Center
Family Planning
Postpartum Family Planning Program in Rwanda
This trial wants to address high unmet need for postpartum family planning (PPFP) in Rwanda. A previous pilot study tested the intervention (informed by formative work with couples/clients, clinic providers, champions, and…
- Trial name
- NCT05056545
- Testing
- C4 Intervention
- Where
- Rwanda
- Volunteers
- 38,220 people
- Sponsor
- Emory University
Acute Hypoxemia
Building Respiratory Support in East Africa Through High Flow Versus Standard Flow Oxygen Evaluation
Acute hypoxemia is common and deadly in resource variable settings. While studies in high income countries (HICs) have indicated a possible benefit to high flow oxygen as compared with standard flow oxygen, rigorous studies in…
- Trial name
- BREATHE (NCT05754034)
- Testing
- High flow oxygen, Standard flow oxygen
- Where
- 5 sites in Kenya, Malawi and 1 more
- Volunteers
- 1,600 people
- Sponsor
- Beth Israel Deaconess Medical Center
Pregnant Women
Association of Gestational Cardiovascular Health With Pregnancy Outcomes
Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations.
- Trial name
- NCT05776082
- Testing
- Questionnaire survey and specimen collection
- Where
- 3 sites in China, Rwanda
- Volunteers
- 5,000 people
- Sponsor
- Women's Hospital School Of Medicine Zhejiang University
Breast Cancer, Cervical Cancer
Breast and Cervical Cancer Stigma in Rwanda
This study aims to assess breast and cervical cancer stigma and pilot a multi-modal intervention to mitigate stigma among patients, caregivers, and community health workers in Rwanda.
- Trial name
- NCT07663006
- Testing
- Behavioral: RISE Intervention, Behavioral: CHW Educational Intervention
- Where
- 2 sites in Rwanda
- Volunteers
- 1,116 people
- Sponsor
- Dana-Farber Cancer Institute
Sepsis
Smart Discharges for Older Children
This study is an observational multi-country cohort study that aims to build algorithms that can identify children between 5 and 16 years of age admitted for proven or suspected sepsis who are at risk of mortality after they are…
- Trial name
- NCT07629154
- Testing
- No Intervention: Observational Cohort
- Where
- 7 sites in United States, Canada and 3 more
- Volunteers
- 4,000 people
- Sponsor
- University of British Columbia
Breast Cancer, Early Detection of Cancer
Strategies to Decentralize Breast Ultrasound in Rwanda
Diagnosing breast cancer early is critical to reduce preventable breast cancer deaths in sub-Saharan Africa. This can be done in part through increasing patients' access to breast ultrasound, which is essential for evaluating…
- Conditions
- Breast Cancer, Early Detection of Cancer, Ultrasonography
- Trial name
- NCT06812208
- Testing
- Teleultrasound with Philips Lumify ultrasound probes and Reacts software, Asynchronous virtual feedback
- Where
- Rwanda
- Volunteers
- 1,792 people, healthy volunteers welcome
- Sponsor
- Brigham and Women's Hospital
Medication Adherence, Breast Cancer
Adjuvant Endocrine Therapy Adherence Intervention Pilot in Rwanda
This study aims to evaluate a multi-modal intervention designed to improve adherence to adjuvant endocrine therapy (AET) among patients with ER-positive breast cancer in Rwanda.
- Trial name
- NCT07562399
- Testing
- Educational video, Symptom monitoring card, Text reminders
- Where
- 4 sites in United States, Rwanda
- Volunteers
- 224 people
- Sponsor
- Dana-Farber Cancer Institute
Surgical Site Infection Following Cesarean Delivery, Cesarean Section Complications
Evaluation of an mHealth-CHW Tool for Post-c-section Follow-up in Rural Rwanda
Cesarean sections (c-sections) are one of the most common surgical procedures done globally. However, there has been an increase in the number of c-section related complications.
- Trial name
- NCT07369700
- Testing
- mHealth Community Health Worker Intervention for post-cesarean follow up
- Where
- Rwanda
- Volunteers
- 1,350 people
- Sponsor
- University of North Carolina, Chapel Hill
Malaria (Plasmodium Falciparum), Malaria Falciparum
Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda
This Phase 1b study will assess the safety, tolerability and pharmacokinetics (PK, this measures the levels of study drug in the body) of a single injection of MMV371 in healthy adult and adolescent participants in Rwanda.
- Conditions
- Malaria (Plasmodium Falciparum), Malaria Falciparum, Malaria Infection, Malaria Prophylaxis
- Trial name
- NCT07548021
- Testing
- MMV371
- Where
- Rwanda
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- Medicines for Malaria Venture
IPV, Mental Health
Rwanda Digital Dashboard Hybrid Type 3 Implementation Study
Mental disorders are leading causes of the health-related burden globally, and in Rwanda the intergenerational mental health consequences of the 1994 Genocide against the Tutsi persist and are further compounded by poverty, such…
- Conditions
- IPV, Mental Health, Discipline Practices, Quality Assurance
- Trial name
- NCT06941831
- Testing
- Digital Dashboard-Supported Sugira Muryango Implementation, Usual Care - Sugira Muryango Implementation
- Where
- Rwanda
- Volunteers
- 1,810 people, healthy volunteers welcome
- Sponsor
- Boston College
Acute Hypoxemic Respiratory Failure
Bag CPAP vs Standard Oxygen Therapy in Acute Hypoxemic Respiratory Failure
Acute Hypoxemic Respiratory Failure (AHRF) is one of the prevalent causes of admission around the world and is associated with high mortality in resource-limited settings.
- Trial name
- BAGCPAP-R (NCT07460427)
- Testing
- Bag CPAP, Standard oxygen
- Where
- Rwanda
- Volunteers
- 250 people
- Sponsor
- Prof RWABIHAMA Jean Paul
Tetanus
TETANUS Antibody Detection in Saliva Study
This study aims to design, develop and optimise a non-invasive, saliva sample-based point-of-care lateral flow test for use in low and middle income settings that can return a qualitative result on whether an individual has or…
- Trial name
- TETANUS (NCT07446166)
- Testing
- Point of care, saliva-based lateral flow test, Blood based immunoassay
- Where
- Rwanda
- Volunteers
- 390 people, healthy volunteers welcome
- Sponsor
- University of Birmingham
Surgery, Inpatients
EMUs: Enhanced Monitoring Using Sensors After Surgery
Patients can become critically unwell following surgical operations. Delay in recognition of this deterioration can result in patient harm and even death.
- Trial name
- EMUs (NCT06565559)
- Testing
- Wearable Wireless Sensor
- Where
- 17 sites in Benin, Ghana and 6 more
- Volunteers
- 1,332 people
- Sponsor
- University of Edinburgh
Hypoxemia, Morality
Health Systems and Policy Contexts of Medical Oxygen
This is a mixed-methods program evaluation from a health systems and policy perspective, involving (i) stakeholder analysis, (ii) policy-implementation gap analysis, and (iii) comparative country case studies.
- Conditions
- Hypoxemia, Morality, Pneumonia
- Trial name
- MOXY-HSP (NCT06169514)
- Testing
- No intervention
- Where
- 6 sites in Cambodia, Laos and 4 more
- Volunteers
- 1 people
- Sponsor
- Murdoch Childrens Research Institute
Human Papilloma Virus, Hiv
Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.
The Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living with HIV: A Prospective, Individual, Double-Blind, Randomized Controlled Study is evaluating immediate or delayed single-dose…
- Trial name
- HOPE II (NCT06436274)
- Testing
- GARDASIL®9, Menveo®/Menactra®
- Where
- 3 sites in Botswana, Rwanda and 1 more
- Volunteers
- 778 people
- Sponsor
- Massachusetts General Hospital
Uncomplicated Plasmodium Falciparum Malaria
A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines
The goal of this open-label randomised, controlled, non-inferiority trial is to assess and compare the efficacy, tolerability and safety of a fixed dose TACT artemether-lumefantrine-amodiaquine (ALAQ) to the ACTs…
- Trial name
- FD-TACT (NCT05951595)
- Testing
- Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL), Artesunate-Amodiaquine (ASAQ)
- Where
- Rwanda
- Volunteers
- 1,680 people
- Sponsor
- University of Oxford